StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

Equities researchers at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note issued to investors on Sunday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Stock Performance

Shares of NASDAQ:CALA opened at $0.01 on Friday. The business has a fifty day moving average of $0.01 and a two-hundred day moving average of $0.01. Calithera Biosciences has a 52-week low of $0.00 and a 52-week high of $0.12.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.